05/13/2026
Reimbursement reductions and new coverage rules for skin substitutes will collide with aggressive investigative activity, making this a critical moment for providers to self-assess. Internal audits and updated compliance protocols early can reduce the risk of recoupment and limit liability in civil or criminal investigations, which are increasingly common in this space. In this article by Andrew Hayes, David Schumacher, Sheryl Xavier, Barri Dean and Heather Romero from Hooper, Lundy & Bookman, P.C., learn more about the economics behind CMS’s policy change, the enforcement trends shaping provider risk, and the practical steps that organizations can adopt to mitigate risk.
Read More:
At the outset of 2026, wound care providers, and skin substitute treatments in particular, are under significant stress from the government on two fronts.